The effect of bone marrow soluble B cell maturation antigen(sBCMA)expression on the efficacy and side effects of chimeric antigen receptor(CAR)-modified T-cell-targeting B cell maturation antigen(BCMA)in patients with multiple myeloma(MM). The gene discussed is TNFRSF17; the disease is plasma cell myeloma.